These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4293590)

  • 21. Primary electron-accepting sites and electron transport reaction in human ceruloplasmin: low-temperature radiolysis study.
    Zgirski A; Gasyna Z; Hilewicz-Grabska M
    FEBS Lett; 1980 May; 113(2):149-52. PubMed ID: 7389887
    [No Abstract]   [Full Text] [Related]  

  • 22. EPR studies on the iron-sulfur centers of DPNH dehydrogenase during the redox cycle of the enzyme.
    Gutman M; Singer TP
    Biochem Biophys Res Commun; 1971 Sep; 44(6):1572-8. PubMed ID: 4334336
    [No Abstract]   [Full Text] [Related]  

  • 23. The stoichiometry of the paramagnetic copper and the oxidation-reduction potentials of type I copper in human ceruloplasmin.
    Deinum J; Vänngård T
    Biochim Biophys Acta; 1973 Jun; 310(2):321-30. PubMed ID: 4352493
    [No Abstract]   [Full Text] [Related]  

  • 24. Ferrous binding to the multicopper oxidases Saccharomyces cerevisiae Fet3p and human ceruloplasmin: contributions to ferroxidase activity.
    Quintanar L; Gebhard M; Wang TP; Kosman DJ; Solomon EI
    J Am Chem Soc; 2004 Jun; 126(21):6579-89. PubMed ID: 15161286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid kinetic evidence for adduct formation between the substrate analog p-nitroso-N,N-dimethylaniline and reduced nicotinamide-adenine dinucleotide during enzymic reduction.
    Dunn MF; Bernhard SA
    Biochemistry; 1971 Nov; 10(24):4569-75. PubMed ID: 4335090
    [No Abstract]   [Full Text] [Related]  

  • 26. Spectroscopic and magnetic studies of human ceruloplasmin: identification of a redox-inactive reduced Type 1 copper site.
    Machonkin TE; Zhang HH; Hedman B; Hodgson KO; Solomon EI
    Biochemistry; 1998 Jun; 37(26):9570-8. PubMed ID: 9649340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaerobic oxidation-reduction titrations of human ceruloplasmin. Evidence for diamagnetic electron-acceptors in the protein.
    Carrico RJ; Malmströn BG; Vänngård T
    Eur J Biochem; 1971 Jun; 20(4):518-24. PubMed ID: 4325877
    [No Abstract]   [Full Text] [Related]  

  • 28. Anion-binding and the state of copper in caeruloplasmin.
    Byers W; Curzon G; Garbett K; Speyer BE; Young SN; Williams RJ
    Biochim Biophys Acta; 1973 May; 310(1):38-50. PubMed ID: 4351064
    [No Abstract]   [Full Text] [Related]  

  • 29. [Spectral characteristics of the mechanism of oxidase activity of ceruloplasmin].
    Vasil'ev VB; Neĭfakh SA; Rusakov DV; Iakovleva TIu; Kholmogorov VE
    Biokhimiia; 1988 Apr; 53(4):620-5. PubMed ID: 2840128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of reduced type 1 copper in ceruloplasmin as revealed by reaction with hydrogen peroxide.
    Calabrese L; Leuzzi U
    Biochem Int; 1984 Jan; 8(1):35-9. PubMed ID: 6089818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of anions on the oxidase activity of rat ceruloplasmin.
    Lovstad RA; Frieden E
    Acta Chem Scand; 1973; 27(1):121-6. PubMed ID: 4144347
    [No Abstract]   [Full Text] [Related]  

  • 32. Siectrophotometric and electron-spin resonance studies of complexes of catecholamines with Cu(II) ions and the interaction of ceruloplasmin with catecholamines.
    WALAAS E; WALAAS O; HAAVALDSEN S
    Arch Biochem Biophys; 1963 Jan; 100():97-109. PubMed ID: 13998406
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride.
    Schosinsky KH; Lehmann HP; Beeler MF
    Clin Chem; 1974 Dec; 20(12):1556-63. PubMed ID: 4214636
    [No Abstract]   [Full Text] [Related]  

  • 34. Modification by cyanide of the aniline-binding reaction with cytochrome P-450.
    Matsubara T; Tochino Y
    Arch Biochem Biophys; 1976 Feb; 172(2):696-705. PubMed ID: 176943
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction of phenothiazine derivatives with human ceruloplasmin.
    Lovstad RA
    Biochem Pharmacol; 1974 Mar; 23(6):1045-52. PubMed ID: 4151049
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparative study of the two different activities of ceruloplasmin in human sera.
    Lovstad RA
    Eur J Biochem; 1969 Mar; 8(2):303-6. PubMed ID: 5781281
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of ceruloplasmin with L- and D-dopa.
    Lovstad RA
    Acta Chem Scand; 1972; 26(7):2832-6. PubMed ID: 4650325
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of promazine with human ceruloplasmin.
    Løvstad RA
    Int J Biochem; 1987; 19(7):649-52. PubMed ID: 3622897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for obtaining linear reciprocal plots with caeruloplasmin and its application in a study of the kinetic parameters of caeruloplasmin substrates.
    Young SN; Curzon G
    Biochem J; 1972 Sep; 129(2):273-83. PubMed ID: 4643313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The electron pathway to Cu(II) in ceruloplasmin.
    Faraggi M; Pecht I
    J Biol Chem; 1973 May; 248(9):3146-9. PubMed ID: 4700454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.